CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions
- 30 June 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 3 (6) , 611-621
- https://doi.org/10.1016/0968-0896(95)00048-l
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Duocarmycins, new antitumor antibiotics produced by Streptomyces; Producing organisms and improved production.The Journal of Antibiotics, 1991
- Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC-1065/duocarmycin common pharmacophoreThe Journal of Organic Chemistry, 1990
- Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp.The Journal of Antibiotics, 1990
- Antitumor activity of pyrindamycins A and B.The Journal of Antibiotics, 1989
- Structures of Duocarmycins, novel antitumor antibiotics produced by Streptomyces sp.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Pyrindamycins A and B, new antitumor antibiotics.The Journal of Antibiotics, 1988
- Duocarmycin A, a new antitumor antibiotic from Streptomyces.The Journal of Antibiotics, 1988
- DC89-A1, a new antitumor antibiotic from Streptomyces.The Journal of Antibiotics, 1988
- The structure of CC-1065, a potent antitumor agent and its binding to DNAJournal of the American Chemical Society, 1981
- CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism.The Journal of Antibiotics, 1978